AGRX - Agile Therapeutics EPS beats by $0.02 August, 11 2020 04:05 PM Agile Therapeutics Inc. Agile Therapeutics (NASDAQ:AGRX): Q2 GAAP EPS of -$0.12 beats by $0.02.Cash and Cash Equivalents of $87.2M.Shares +1.9%.Press ReleaseMore news on: Agile Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,